Woods J A, Hadfield J A, Pettit G R, Fox B W, McGown A T
CRC Department of Experimental Chemotherapy, Paterson Institute for Cancer Research, Christie Hospital, Manchester, UK.
Br J Cancer. 1995 Apr;71(4):705-11. doi: 10.1038/bjc.1995.138.
A series of stilbenes, based on combretastatin A-4, were synthesised. A structure-activity study was carried out to characterise the interaction of these agents with tubulin. The substitution of small alkyl substituents for the 4'-methoxy group of combretastatin A-4 and the loss of the 3'-hydroxyl group does not have a major effect on the interaction with tubulin. trans-Stilbenes were shown to bind tubulin, but do not inhibit microtubule assembly. This work, together with previous studies, has been used to propose an idealised structure for a tubulin-binding agent of this type.
合成了一系列基于康普他汀A - 4的芪类化合物。开展了一项构效关系研究,以表征这些药物与微管蛋白的相互作用。用小烷基取代基替换康普他汀A - 4的4'-甲氧基以及失去3'-羟基对与微管蛋白的相互作用没有重大影响。反式芪类化合物被证明能结合微管蛋白,但不抑制微管组装。这项工作与之前的研究一起,已被用于提出此类微管蛋白结合剂的理想化结构。